Stay updated on Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3. No other content changes.
    Difference
    0.1%
    Check dated 2026-03-11T14:46:45.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 banner was added and an older government funding/operating-status notice (v3.4.1) was removed, as a housekeeping update that does not affect study details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T01:35:59.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding lapse notice at the top of the page with guidance to visit cc.nih.gov and opm.gov for updates. Updated site revision from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-03T23:34:56.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI updates include a new 'Show glossary' option, capitalization tweaks (Last Update Submitted that Met QC Criteria vs met QC Criteria and No FEAR Act Data vs No FEAR Act data), and an updated Revision: v3.4.0 (replacing v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T21:08:42.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Revision note updated from v3.3.3 to v3.3.4 on the page. This change does not modify any study content, eligibility criteria, results, or other user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-20T15:39:38.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a dedicated Locations section showing Pennsylvania as a study site, and updated the page revision to v3.3.3. Removed the Pennsylvania Locations subheading and HHS Vulnerability Disclosure link, and replaced v3.3.2 with v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-22T22:02:52.000Z thumbnail image

Stay in the know with updates to Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial page.